The antioxidative role of Aegle marmelos Linn. on colchicine induced experimental rat model of Alzheimer’s disease
DOI:
https://doi.org/10.55184/ijpas.v77i01.296Keywords:
Antioxidant, Neurodegenerative diseases, Alzheimer's disease, Aegle marmelos, Colchicine, Radial Y arm mazeAbstract
Antioxidant plays a crucial role in the management of neurodegenerative diseases including Alzheimer's disease. A number of Indian medicinal plants have been used in the traditional system of medicine (Ayurveda) for the management of neurodegenerative diseases including Alzheimer's disease. Some of these plants have already been reported to possess strong antioxidant activity. Aegle marmelos (AM) Linn., a fruit of common use, is rich in vit-E, beta-carotene, flavonoids and flavonols. The effect of chronic oral treatment of aqueous pulp extract of AM (250 mg/ kg B.W) was studied in Holtzman strain adult albino rats of both sexes. The behaviour study, antioxidant level Superoxide dismutase (SOD), Catalase (CAT), Reduced glutathione level (GSH) and Lipid peroxidation level were studied in different brain areas such as Cerebral cortex (CC), Cerebellum (CB), Midbrain (MB), Caudate nucleus (CN) and Pons & Medulla (PM) in colchicine induced experimental Alzheimer rat model before and after treatment with AM. The result revealed that chronic treatment with AM pulp extract markedly increased the number of correct choices in radial Y arm maze task, significantly decreased Lipid peroxidation level, significantly increased SOD, CAT and Reduced glutathione level in the different parts of the brain. The present study demonstrated that the antioxidant property of AM property may be beneficial for the management of colchicine induced rat model of Alzheimer's disease.
References
Rahman S, Parvin R. Therapeutic potential of Aegle marmelos (L.)-An overview. Asian Pac J Trop Dis. 2014;4(1):71-77. doi:10.1016/S2222-1808(14)60318-2.
Maity P, Hansda D, Bandyopadhyay U, Mishra DK. Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.). Corr. Indian J Exp Biol. 2009;47(11):849-861.
Jagetia GC, Venkatesh P, Baliga MS. Evaluation of the radioprotective effect of Aegle marmelos (L.) Correa in cultured human peripheral blood lymphocytes exposed to different doses of gamma-radiation: A micronucleus study. Mutagenesis. 2003;18:387–93. [PubMed] [Google Scholar]
Vidhya N, Devaraj SN. Antioxidant effect of eugenol in rat intestine. Indian J Exp Biol. 1999;37:1192–5. [PubMed] [Google Scholar]
Ogata M, Hoshi M, Urano S, Endo T. Antioxidant activity of Eugenol and related monomeric and dimeric compounds. Chem Pharm Bull (Tokyo). 2000;48:1467–9. [PubMed] [Google Scholar]
Nagashima K. Inhibitory effect of Eugenol on Cu2+- catalyzed lipid peroxidation in human erythrocyte membranes. Int J Biochem. 1989;21:745–9. [PubMed] [Google Scholar]
Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos - and - its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004;48:81–8. [PubMed] [Google Scholar]
Adavala PD, Musukula YR, Puchchakayala G. Neuroprotective effect of Aegle marmelos leaf extract in scopolamine induced cognitive impairment and oxidative stress in mice. Global J Pharmacol. 2016;10(2):45-53.
Manandhar B, Paudel KR, Sharma B, Karki R. Phytochemical profile and pharmacological activity of Aegle marmelos Linn. J Integr Med. 2018;16(3):153-163. doi:10.1016/j.joim.2018.04.007.
Rajan S, Gokila M, Jency P, Brindha P, Sujatha RK. Antioxidant and phytochemical properties of Aegle marmelos fruit pulp. Int J Curr Pharm Res. 2011;3:65-70.
Baliga MS, Bhat HP, Joseph N, Fazal F. Phytochemistry and medicinal uses of the bael fruit (Aegle marmelos Correa): a Concise review. Food Res Int. 2011;44(7):1768-1775. doi:10.1016/j.foodres.2011.02.008.
Ladaniya MS. Citrus fruit biology technology and - evaluation. Waltham, Massachusetts: Academic Press; 2008. pp. 1–558. [Google Scholar].
Terry RD, Davies P. Dementia of the Alzheimer type. Annu Rev Neurosci. 1980; 3: 77-95.
Wisniewski HM, Iqbal K. Aging of the brain and dementia. Trends Neurosci. 1980; 3: 226-228.
Roy C, Ghosh TK, Guha D. The antioxidative role of Benincasa hispida on colchicine induced experimental rat model of Alzheimer’s disease. Biogenic Amines. 2007; 21(1-2): 44-57.
Ball MJ. Neurofibrillary tangles and the pathogenesis of dementia: a quantitative study. Neuropathol Appl Neurobiol. 1976; 2: 395-410.
Tomlinson BE, Blessed G Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970; 11: 205-242.
Irizarry M, Hyman B. Alzheimer’s disease. In: Batchlor T, Cudkowicz M, editors. Principles of neuroepidemiology. Boston: Butterworth-Heinemann. 2001; pp: 69-98.
Scheltens P, Blennow K, Breteler MMB. Alzheimer's disease. Lancet. 2016; 388(10043):505-517. doi:10.1016/S0140-6736(15)01124-1.
Flaherty CF, Rowan GA, Emrich DF, Walsh TJ. Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance. Behav Neurosci. 1989; 103: 319-328.
Sofroniew MV, Peareson RCA, Isacson O, Bjorklund A. Experimental studies on the induction and prevention of retrograde degeneration of basal forebrain cholinergic neurons. Prog Brain Res. 1986; 70: 363 – 389.
Tilson HA, Peterson N. Colchicine as an investigative tool in neurobiology. Toxicology. 1987; 46: 159 – 173.
Tilson HA, McLamb RL, Shaw S, Rogers BC, Pediaditakis P, Cook L. Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents. Brain Res. 1988; 438: 83 – 94.
McClure WO. Effects of drugs upon axoplasmic transport. Adv Pharmacol Chemother.1972; 10: 185 – 220.
Wisniewski H, Terry RD. Experimental colchicine encephalography. Induction of neurofibrillary degeneration. Lab Invest. 1967; 17: 577 – 587.
Goldschmidt RB, Steward O. Neurotoxic effects of colchicines differential susceptibility of CNS neuronal populations. Neuroscience. 1982; 7: 695-714.
Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N. Oxidative damage in Alzheimer’s. Nature. 1996; 382: 120-121.
Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997; 23: 134–147.
Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology. 1995; 45: 1594–1601.
Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG and Montine TJ. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer’s disease is associated with inheritance of APOE4. Am J Pathol .1997; 150: 437 – 443.
Schippling S, Kontush A, Arlt S, Buhmann C, Sturenburg HJ, Mann U, Muller-Thomsen T, Beisiegel U. Increased lipoprotein oxidation in Alzheimer’s disease. Free Radic Biol Med. 2000; 28: 351 – 360.
McGrath LT, McGleenon BA, Brennan S, McColl D, MclLroy S, Passmore AP. Increased oxidative stress in Alzheimer’s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM. 2001; 94: 485 – 490.
Johnston MV. Cognitive disorders. In: Principles of Drug Therapy in Neurology, M.V. Johnston, R.L. Macdonald and A.B. Young (Eds.) Davis Philadelphia. 1992; pp: 226—267.
Mayeux R, Sano M. Treatment of Alzheimer’s disease. N Engl J Med. 1999; 341: 1670-1679.
Das SK, Roy C. The Protective Role of Aegle Marmelos on Aspirin–Induced Gastro-Duodenal Ulceration in Albino Rat Model: A Possible Involvement of Antioxidants. Saudi J Gastroenterol. 2012; 18(3): 188–194. doi: 10.4103/1319-3767.96452.
Pellegrino LJ, Cushman AJ. A stereotaxic atlas of the rat brain. Appleton Century Crafts. New York. 1967; pp: 60.
Dwaine FE, Thoams JW. Cholinergic cell loss and cognitive impairments following intracerebroventricular of intradentate injection of colchicine. Brain Res. 1990; 517: 157-167.
Mishra HP, Fridovich I. The generation of radical during superoxide auto oxidation of hemoglobin. J Biol Chem. 1972;34:30–7. [Google Scholar].
Roy C, Ghosh TK, Guha D. Dose dependent activity of Benincasa hispida on colchicine induced experimental rat model of Alzheimer's disease. Int J Pharmacol. 2008;4:237–44. [Google Scholar].
Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970;34:30–8. [PubMed] [Google Scholar].
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82: 70-77.
Hazra R, Ray K, Guha D. Inhibitory role of Acorus calamus in ferric chloride induced epileptogenesis in rat. Hum Exp Toxicol. 2007; 26:947–53. [PubMed] [Google Scholar].
Simonian NA, Coyle ST. Oxidative stress in neudegenerative diseases. Annu Rev Pharmacol Toxicol. 1996; 36: 83 – 106.
Beal F. Aging, energy and oxidative stress in neurodegenarative diseases. Annals of Neurology. 1995; 38(3): 357-366.
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha tocopherol or both as treatment for Alzheimer’s disease. The Alzheimer’s disease Cooperative Study. N Engl J Med. 1997; 336: 1216-1222.
Mitchell JJ, Paiva M, Heaton MB. Vitamin E and beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippocampal culture model of fetal alcohol syndrome. Neurosci Lett. 1999; 263(2-3): 189 – 192.
Yu Z, Cheng G, Hu B. Mechanism of colchicine impairment on learning and memory, and protective effect of CGP36742 in mice. Brain Res. 1997; 750: 53 – 58.
Hammer B, Parker WD, Bennett JP. NMDA receptors increase OH radicals in vivo by using nitric oxide synthase and protein kinase C. Neuro Report. 1993; 5: 72 – 74.
Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta. 2001; 1535: 145-152.
Reiter RJ. Melatonin: lowering the high price of free radicals. News Physiol Sci.2000; 15: 246-250.
Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem. 2000; 267(16): 4904-4911.
Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry. 1998; 13: 749-54.
Clement M, Bourre JM. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha and gamma tocopherol in nervous tissues, heart, liver and muscle of vitamin E deficient rats. Biochim Biophys Acta. 1997; 1334: 173 – 181.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Chandan Roy
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.